nanoparticle formulation p53
Nanoparticle formulation p53 is in advanced pre-clinical testing and has demonstrated a good safety profile and promising anti-cancer activity in animal studies. INGN 402 contains the p53 tumor suppressor.
| Cancer Indication | Status |
| Various cancers | Pre-clinical |
** We hold the worldwide commercial rights to the product candidates related to each of these programs.
